tm logo
GENERICS BEST
Dead/Abandoned
ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE

failure to respond or late response

on 25 Apr 2011

Last Applicant/ Owned by

3331 Summit Blvd

Pensacola

US

FL

32503

Serial Number

85067836 filed on 21st Jun 2010

Registration Number

N/A

Correspondent Address

PENSACOLA, FL 32503-8300

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

GENERICS BEST

Analgesic and muscle relaxant pharmaceutical preparations; Anti-diabetic pharmaceuticals; Antibacterial pharmaceuticals; Astringents; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Injectable pharmaceuticals for treatment of anaphylactic reactions; Ocular pharmaceuticals; Pharmaceu Read More

Classification Information


Class [005]
Pharmaceutical Products


Analgesic and muscle relaxant pharmaceutical preparations; Anti-diabetic pharmaceuticals; Antibacterial pharmaceuticals; Astringents; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Injectable pharmaceuticals for treatment of anaphylactic reactions; Ocular pharmaceuticals; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti- infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations for chloasma; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations for pregnancy blemishes; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products and preparations to prevent stretch marks; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for ophthalmological use; Pharmaceutical products for skin care for animals; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical skin lotions; Pharmaceutical solutions used in dialysis; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals, namely, anti-infectives; Pharmaceuticals, namely, antihelmintics; Pharmaceuticals, namely, inducers of erections; Pharmaceuticals, namely, lipid lowering agents; Pharmaceuticals, namely, psychotropics; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Radioactive pharmaceutical preparations for use in vivo diagnostic or therapeutic use

Class [029]
Meats and Processed Food Products


Cheese food; Dairy-based chocolate food beverages; Dairy-based food beverages; Dairy-based snack foods excluding ice cream, ice milk and frozen yogurt; Food package combinations consisting primarily of cheese, meat and/or processed fruit; French fry food item consisting primarily of french fries, but also including gravy and toppings; Fruit and soy based snack food; Fruit-based food beverage; Fruit-based organic food bars; Fruit-based snack food; Lard for food; Meat-based snack foods; Nut-based snack foods; Nut-based snack foods, namely, nut clusters; Nut-based snack foods, namely, nut crisps; Peanut-based food beverages; Potato-based snack foods; Powdered milk for food purposes; Prepared food kits composed of meat, poultry, fish, seafood, and/or vegetables and also including sauces or seasonings, ready for cooking and assembly as a meal; Processed fruit- and nut-based food bars; Refrigerated food package combinations consisting primarily of meat, cheese or processed vegetables for purposes of creating a sandwich; Snack food dips; Soy-based food bars; Soy-based food beverage used as a milk substitute; Soy-based snack foods; Vegetable-based chocolate food beverages; Vegetable-based food beverages; Vegetable-based snack foods

Class [030]
Staple Food Products


Candy for food; Cereal based snack food; Cereal-based snack foods; Chocolate food beverages not being dairy-based or vegetable based; Chocolate-based ready-to-eat food bars; Cocoa-based condiments and seasonings for food and drink; Confectioneries, namely, snack foods, namely, chocolate; Corn-based snack foods; Dough-enrobed foods consisting of a dough-based wrapper with fillings consisting primarily of ice cream and other dairy-based desserts; Dough-enrobed foods consisting of a dough-based wrapper with fillings consisting primarily of meats, poultry, fish, fruits and vegetables and cheese; Dough-enrobed foods consisting of a dough-based wrapper with fillings consisting primarily of pasta and rice; Flour for food; Food condiment consisting primarily of ketchup and salsa; Food leavening agents; Food package combinations consisting primarily of bread, crackers and/or cookies; Frozen foods, namely, grain and bread based appetizers, hors d'oeuvres, and canapés; Grain-based food beverages; Grain-based snack foods; Herb tea; Herbal food beverages; Herbal tea; Honey; Malt for food purposes; Mixes for making batters for fried foods; Multigrain-based snack foods; Potato flour; Processed cereal-based food to be used as a breakfast food, snack food or ingredient for making other foods; Ready to eat, cereal derived food bars; Rice-based snack foods; Salt for preserving food; Snack foods, namely, chocolate-based snack foods; Wheat flour; Wheat-based snack foods

Mark Details


Serial Number

No 85067836

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Status DateAction Taken
25th Apr 2011ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
25th Apr 2011ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
27th Sep 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
27th Sep 2010NON-FINAL ACTION E-MAILED
27th Sep 2010ASSIGNED TO EXAMINER
27th Sep 2010NON-FINAL ACTION WRITTEN
24th Jun 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
24th Jun 2010NEW APPLICATION ENTERED IN TRAM